Extracorporeal life support does not reduce death risk in acute MI, cardiogenic shock healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Sotatercept, a designer molecule that removes a key driver of pulmonary arterial hypertension, was efficacious and safe in the first of three pivotal trials.
NEW ORLEANS — A therapeutic vs. prophylactic dose of anticoagulation therapy did not significantly improve outcomes for noncritically ill patients hospitalized with COVID-19, though fewer therapeutic dose-treated patients died at 30 days.The FREEDOM COVID trial ultimately did not meet its primary endpoint — a 30-day composite of all-cause mortality, ICU admission, systemic